NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Pharmacokinetics of Scopolamine Intranasal Gel Formulation (INSCOP) During Antiorthostatic BedrestSpace Motion sickness (SMS) is an age old problem for space travelers on short and long duration space flight Oral antiemetics are not very effective in space due to poor bioavailability. Scopolamine (SCOP) is the most frequently used drug by recreational travelers V patch, tablets available on the market. Common side effects of antiemetics, in general, include drowsiness, sedation, dry mouth and reduced psychomotor performance. Severity and persistence of side effects are often dose related Side effects can be detrimental in high performance demanding settings, e.g. space flight, military.
Document ID
20110011043
Acquisition Source
Johnson Space Center
Document Type
Presentation
Authors
Putcha, Lakshmi
(NASA Johnson Space Center Houston, TX, United States)
Boyd, J. L.
(Simulations Plus Lancaster, CA, United States)
Du, B.
(Prairie View Agricultural and Mechanical Coll. TX, United States)
Daniels, V.
(Wyle Labs., Inc. Houston, TX, United States)
Crady, C.
(Wyle Labs., Inc. Houston, TX, United States)
Date Acquired
August 25, 2013
Publication Date
April 11, 2011
Subject Category
Aerospace Medicine
Report/Patent Number
JSC-CN-23437
Report Number: JSC-CN-23437
Meeting Information
Meeting: 18th IAA Humans in Space Symposium
Location: Houston, TX
Country: United States
Start Date: April 11, 2011
End Date: April 15, 2011
Sponsors: International Academy of Astronautics
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available